How to cite item

KEYNOTE-042: is lowering the PD-L1 threshold for first-line pembrolizumab monotherapy a good idea?

  
@article{TLCR28795,
	author = {Jose M. Pacheco},
	title = {KEYNOTE-042: is lowering the PD-L1 threshold for first-line pembrolizumab monotherapy a good idea?},
	journal = {Translational Lung Cancer Research},
	volume = {8},
	number = {5},
	year = {2019},
	keywords = {},
	abstract = {Prior to the advent of inhibitory antibodies targeting programmed death 1 (PD-1) or programmed death ligand 1 (PD-L1), the median overall survival (OS) for advanced/metastatic non-small cell lung cancer (NSCLC) patients receiving first-line platinum doublet chemotherapy was approximately 8–12 months and 5-year survival rates were estimated at 2% (1-3).},
	issn = {2226-4477},	url = {http://tlcr.amegroups.com/article/view/28795}
}